title: Alterations in acute-phase proteins among HIV-1 infected persons receiving generic HAART in southern India.
authors.forename: Muthu
authors.initials: M
authors.lastname: Sundaram
authors.forename: Chakravarthy Narasimhachar
authors.initials: CN
authors.lastname: Srinivas
authors.forename: Esaki Muthu
authors.initials: EM
authors.lastname: Shankar
authors.forename: Pachamuthu
authors.initials: P
authors.lastname: Balakrishnan
authors.forename: Suniti
authors.initials: S
authors.lastname: Solomon
authors.forename: Nagalingeswaran
authors.initials: N
authors.lastname: Kumarasamy
mesh_terms: D000209:Acute-Phase Proteins / Q000276:immunology / Q000378:metabolism*; D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active; D018791:CD4 Lymphocyte Count; D016022:Case-Control Studies; D003167:Complement Activation / Q000276:immunology; D003176:Complement C3 / Q000378:metabolism; D003181:Complement C4 / Q000378:metabolism; D005260:Female; D015658:HIV Infections / Q000097:blood* / Q000188:drug therapy* / Q000276:immunology; D015497:HIV-1; D006801:Humans; D007194:India; D008297:Male
chemical_list: D000209:Acute-Phase Proteins; D019380:Anti-HIV Agents; D003176:Complement C3; D003181:Complement C4